methionine has been researched along with Central Nervous System Neoplasm in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 9 (52.94) | 24.3611 |
| 2020's | 4 (23.53) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, K; Ikeguchi, R; Kawamata, T; Kitagawa, K; Masui, K; Mizuno, T; Muragaki, Y; Nitta, M; Oshima, R; Shibata, N; Shimizu, Y; Wako, S; Yamamoto, T | 1 |
| Bedekovics, J; Kurdi, N; Mehes, G; Mokanszki, A | 1 |
| Cho, HW; Choe, YS; Choi, JY; Lee, H; Lee, JW; Lee, KH; Moon, SH; Sung, KW | 1 |
| Katai, H; Kurihara, H; Miyakita, Y; Narita, Y; Ohno, M; Takahashi, M | 1 |
| Falk Delgado, A | 1 |
| Ahn, JS; Ahn, SY; Bom, HS; Jung, SH; Ki, SY; Kim, HJ; Kwon, SY; Lee, JJ; Min, JJ; Song, SY; Yang, DH; Yoo, SW | 1 |
| Ando, Y; Fujii, M; Kato, K; Maesawa, S; Naganawa, S; Nihashi, T; Okada, Y; Okochi, Y; Takebayashi, S; Wakabayashi, T | 1 |
| Baquero, M; Bassa, P; García-Garzon, JR; Riera, E; Soler, M; Villasboas-Rosciolesi, D | 1 |
| Bangard, C; Glasmacher, A; Jürgens, A; Linnebank, M; Moskau, S; Orlopp, K; Pels, H; Schlegel, U; Schmidt-Wolf, IG; Semmler, A; Simon, M; Urbach, H; Vogt-Schaden, M | 1 |
| Guenther, M; Hebart, H; Herrlinger, U; Knop, S; Korfel, A; Kurzwelly, D; Linnebank, M; Loeffler, J; Simon, M; Thiel, E; Weller, M | 1 |
| Kawai, N; Maeda, Y; Miyake, K; Nishiyama, Y; Okubo, S; Tamiya, T; Yamamoto, Y | 1 |
| Kameyama, R; Kawai, N; Kawase, Y; Kudomi, N; Nishiyama, Y; Yamamoto, Y | 1 |
| Guillevin, R; Noël, G | 1 |
| Bangard, C; Egerer, G; Kowoll, A; Linnebank, M; Moskau, S; Pels, H; Reichmann, H; Schackert, G; Schlegel, U; Schmidt-Wolf, IG; Semmler, A; Vogt-Schaden, M | 1 |
| Ahmed, MM; Chada, S; Kokkinakis, DM; Liu, X; Luo, J; Shareef, MM; Singha, UK; Yang, S | 1 |
| Farmand, S; Fliessbach, K; Kleczar, N; Klockgether, T; Linnebank, M; Orlopp, K; Pels, H; Schlegel, U; Schmidt-Wolf, IG; Urbach, H | 1 |
| Feldkamp, MM; Guha, A; Lau, N | 1 |
2 review(s) available for methionine and Central Nervous System Neoplasm
| Article | Year |
|---|---|
Histone H3 K27 alterations in central nervous system tumours: Challenges and alternative diagnostic approaches.
Topics: Central Nervous System Neoplasms; Child; Glioma; Histones; Humans; Lysine; Methionine | 2022 |
Discrimination between primary low-grade and high-grade glioma with
Topics: Central Nervous System Neoplasms; Glioma; Humans; Likelihood Functions; Methionine; Neoplasm Grading; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2018 |
15 other study(ies) available for methionine and Central Nervous System Neoplasm
| Article | Year |
|---|---|
IgG4-related brain pseudotumor mimicking CNS lymphoma. A case report.
Topics: Adult; Brain; Central Nervous System Neoplasms; Diagnosis, Differential; Female; Humans; Immunoglobulin G; Lymphoma; Methionine | 2022 |
Methionine metabolism and endocrine function of the pituitary gland in patients with suprasellar germinoma.
Topics: Central Nervous System Neoplasms; Follicle Stimulating Hormone; Germinoma; Head and Neck Neoplasms; Humans; Luteinizing Hormone; Methionine; Pituitary Gland; Positron Emission Tomography Computed Tomography; Thyrotropin | 2023 |
Usefulness of carbon-11-labeled methionine positron-emission tomography for assessing the treatment response of primary central nervous system lymphoma.
Topics: Adult; Aged; Central Nervous System Neoplasms; Female; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Positron-Emission Tomography; ROC Curve; Treatment Outcome | 2020 |
Prognostic Significance of Interim 11C-Methionine PET/CT in Primary Central Nervous System Lymphoma.
Topics: Adult; Aged; Carbon Radioisotopes; Central Nervous System Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methionine; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Clinical use of (11)C-methionine and (18)F-FDG-PET for germinoma in central nervous system.
Topics: Adolescent; Adult; Brain; Carbon Radioisotopes; Central Nervous System Neoplasms; Child; Female; Fluorodeoxyglucose F18; Germinoma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Methionine; Nerve Fibers, Myelinated; Nerve Fibers, Unmyelinated; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2014 |
A False-Negative Case of Primary Central Nervous System Lymphoma on 11C-Methionine PET and Intense 18F-FDG Uptake.
Topics: Adult; Carbon Radioisotopes; Central Nervous System Neoplasms; False Negative Reactions; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Methionine; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma.
Topics: Antimetabolites, Antineoplastic; Brain; Central Nervous System Neoplasms; Cystathionine beta-Synthase; Female; Humans; Hydroxymethyl and Formyl Transferases; Lymphoma; Male; Methionine; Methionine Sulfoxide Reductases; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Microfilament Proteins; Middle Aged; Multienzyme Complexes; Nucleotide Deaminases; Oxidoreductases; Polymorphism, Genetic; Prospective Studies; Tetrahydrofolate Dehydrogenase; Transcobalamins; Transcription Factors; TRPM Cation Channels | 2009 |
Genetic variants of folate and methionine metabolism and PCNSL incidence in a German patient population.
Topics: Adult; Aged; Aged, 80 and over; Central Nervous System Neoplasms; Female; Folic Acid; Genetic Predisposition to Disease; Genotype; Germany; Humans; Incidence; Lymphoma; Male; Methionine; Middle Aged; Polymorphism, Single Nucleotide; White People | 2010 |
Use of PET in the diagnosis of primary CNS lymphoma in patients with atypical MR findings.
Topics: Adult; Aged; Central Nervous System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2010 |
Comparison of 11C-methionine PET and 18F-FDG PET in patients with primary central nervous system lymphoma.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Central Nervous System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Lymphoma; Male; Methionine; Middle Aged; Positron-Emission Tomography; Radiography | 2011 |
[Delineation of glioblastoma, simplicity to complexity, the contribution of imaging].
Topics: Carbon Radioisotopes; Central Nervous System Neoplasms; Clinical Trials as Topic; Diagnostic Imaging; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Methionine; Neoplasm Recurrence, Local; Organs at Risk; Positron-Emission Tomography; Radiopharmaceuticals; Societies, Medical; Tomography, X-Ray Computed; Tumor Burden | 2011 |
Association of transcobalamin c. 776C>G with overall survival in patients with primary central nervous system lymphoma.
Topics: Adult; Aged; Central Nervous System Neoplasms; Female; Genotype; Humans; Lymphoma; Male; Methionine; Methotrexate; Middle Aged; Mutation, Missense; Survival Analysis; Transcobalamins | 2012 |
Modulation of gene expression in human central nervous system tumors under methionine deprivation-induced stress.
Topics: Apoptosis; Astrocytoma; Cell Cycle; Cell Line, Tumor; Central Nervous System Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Medulloblastoma; Methionine; NF-kappa B | 2004 |
MTX-induced white matter changes are associated with polymorphisms of methionine metabolism.
Topics: Aged; Brain; Central Nervous System Neoplasms; Demyelinating Diseases; DNA Mutational Analysis; Drug Resistance; Female; Folic Acid; Folic Acid Antagonists; Gene Frequency; Genetic Predisposition to Disease; Genetic Testing; Haplotypes; Humans; Lymphoma; Male; Methionine; Methotrexate; Middle Aged; Myelin Sheath; Nerve Fibers, Myelinated; Neurotoxins; Polymorphism, Genetic; Risk Factors; S-Adenosylmethionine | 2005 |
Growth inhibition of astrocytoma cells by farnesyl transferase inhibitors is mediated by a combination of anti-proliferative, pro-apoptotic and anti-angiogenic effects.
Topics: Alkyl and Aryl Transferases; Angiogenesis Inhibitors; Antineoplastic Agents; Apoptosis; Astrocytoma; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Bromodeoxyuridine; Cell Cycle; Cell Division; Central Nervous System Neoplasms; Dose-Response Relationship, Drug; Endothelial Growth Factors; Enzyme Inhibitors; ErbB Receptors; Farnesyltranstransferase; Genes, ras; Growth Inhibitors; Humans; Lymphokines; Membrane Proteins; Methionine; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myelin Basic Protein; Neovascularization, Pathologic; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1999 |